9 articles8,713 citations
The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine.
Wright, Dawson-Hughes·J Bone Miner Res·2014·1,773 citations
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Saag, Grauer·N Engl J Med·2017·1,486 citations
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.Citation only
Saag, Daifotis·N Engl J Med·1998·1,276 citations
The Clinician’s Guide to Prevention and Treatment of Osteoporosis
LeBoff, Siris·Osteoporosis International·2022·1,242 citations
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis.Citation only
Saag, Marcus·N Engl J Med·2007·919 citations
2015 Gout Classification Criteria: An American College of Rheumatology/european League Against Rheumatism Collaborative Initiative.Citation only
Neogi, Taylor·Arthritis Rheumatol·2015·672 citations
The Clinical Diagnosis of Osteoporosis: A Position Statement from the National Bone Health Alliance Working Group.
Siris, Watts·Osteoporos Int·2014·659 citations
Obesity Is Not Protective Against Fracture in Postmenopausal Women: GLOW.
Compston, Siris·Am J Med·2011·546 citations
Denosumab versus Risedronate in Glucocorticoid‐induced Osteoporosis: Final Results of a Twenty‐four–month Randomized, Double‐blind, Double‐dummy TrialCitation only
Saag, Lems·Arthritis Rheumatol·2019·140 citations